These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9916381)

  • 1. Effects of long-term treatment with depot medroxy progesterone acetate for contraception on estrogenic activity.
    Taneepanichskul S; Patrachai S
    J Med Assoc Thai; 1998 Dec; 81(12):944-6. PubMed ID: 9916381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
    Mishell DR
    J Reprod Med; 1996 May; 41(5 Suppl):381-90. PubMed ID: 8725700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Lobo RA; McCormick W; Singer F; Roy S
    Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Shaarawy M; El-Mallah SY; Seoudi S; Hassan M; Mohsen IA
    Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid receptor expression in vaginal epithelium of healthy fertile women and influences of hormonal contraceptive usage.
    Ildgruben A; Sjöberg I; Hammarström ML; Bäckström T
    Contraception; 2005 Nov; 72(5):383-92. PubMed ID: 16246667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
    Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of medroxyprogesterone acetate contraception on human serum enzymes.
    Mukherjea M; Mukherjee P; Biswas R; Chakraborty AS; Kushari J
    Int J Fertil; 1981; 26(1):35-9. PubMed ID: 6113206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of safety in Chinese women with amenorrhea following injection of depot-medroxyprogesterone for contraception].
    Zhu M; Lei Z; Yang D
    Zhonghua Fu Chan Ke Za Zhi; 1999 Oct; 34(10):621-3. PubMed ID: 11477805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Injectable contraceptive, DMPA, serum HDL cholesterol and heart infarct].
    Kremer J; de Bruijn HW; Hindriks FR
    Ned Tijdschr Geneeskd; 1981 Aug; 125(35):1418-21. PubMed ID: 6456421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P; Bottazzi M; Steel SA
    Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactorrhea in DMPA users: incidence and clinical significance.
    Gongsakdi D; Rojanasakul A
    J Med Assoc Thai; 1986 Jan; 69(1):28-32. PubMed ID: 2937870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of depot medroxyprogesterone acetate on postpartum depression.
    Tsai R; Schaffir J
    Contraception; 2010 Aug; 82(2):174-7. PubMed ID: 20654759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK; Sowers MR; Nichols S; Levy B
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
    Sereepapong W; Chotnopparatpattara P; Taneepanichskul S; Markham R; Russell P; Fraser IS
    Hum Reprod; 2004 Mar; 19(3):547-52. PubMed ID: 14998949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.
    Ortiz A; Hirol M; Stanczyk FZ; Goebelsmann U; Mishell DR
    J Clin Endocrinol Metab; 1977 Jan; 44(1):32-8. PubMed ID: 833262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body weight and bleeding pattern changes in women using DMPA-SC.
    Chaudhri R; Rizvi F; Afzal M
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):618-21. PubMed ID: 19811711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facts about injectable contraception.
    Contracept Rep; 1994 Mar; 5(1):1-2. PubMed ID: 12287737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.